Catalyst Wire Dossier Catalyst Wire Dossier

90Y-Clivatuzumab Tetraxetan

null · null
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 90Y-Clivatuzumab Tetraxetan, covering 2021-08-16 to 2021-08-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer [Phase 3]

See pricing